Claims
- 1. A method comprising the steps of:
(a) covalently attaching species to the exterior of the fullerene carbon nanocage to form a derivatized fullerene carbon nanocage; and (b) inserting an endohedral doping agent into the derivatized fullerene carbon nanocage.
- 2. The method of claim 1, wherein the derivatized fullerene carbon nanocage is a fluorinated fullerene carbon nanocage.
- 3. The method of claim 1, wherein the step of covalently attaching decreases the potential energy barrier for the step of inserting.
- 4. The method of claim 1, wherein the fullerene carbon nanocage is selected from the group consisting of fullerenes, buckyballs, carbon nanotubes, nested fullerenes, bucky onions, single-wall carbon nanotubes, multi-wall carbon nanotubes, carbon fibrils, and combinations thereof.
- 5. The method of claim 1, wherein the endohedral doping agent is selected from the group consisting of a charged species, a neutral species, ion(s), atom(s), atom clusters, molecules, and combinations thereof.
- 6. The method of claim 5, wherein the endohedral doping agent is radioactive.
- 7. The method of claim 5, wherein the endohedral doping agent is inserted via ion bombardment.
- 8. The method of claim 5, wherein the step of inserting comprises a high-temperature and high-pressure process.
- 9. The method of claim 5, wherein the endohedral doping agent decays into a radioactive species.
- 10. The method of claim 1, further comprising removing at least some of the covalently attached species from the exterior of the fullerene carbon nanocage after the step of inserting.
- 11. The method of claim 1, further comprising adding bio-specific ligands or antibodies to the fullerene nanocage.
- 12. The method of claim 11, wherein the step of adding occurs before the step of attaching.
- 13. The method of claim 11, wherein the step of adding occurs during the step of attaching.
- 14. The method of claim 11, wherein the step of adding occurs between the step of attaching and the step of inserting.
- 15. The method of claim 11, wherein the step of adding occurs after the step of inserting.
- 16. The method of claim 1, wherein the step of inserting comprises breaking and subsequent reformation of carbon-carbon bonds in the fullerene nanocage structure.
- 17. A method comprising:
(a) derivatizing a fullerene; and (b) endohedrally modifying the fullerene.
- 18. The method of claim 17, wherein the fullerene is a fullerene tube.
- 19. The method of claim 18, wherein the fullerene tube is a single-wall carbon nanotube.
- 20. The method of claim 19, wherein the sidewall carbon nanotube is derivatized on the sidewall of the single-wall carbon nanotube.
- 21. A composition comprising:
(a) a fullerene; (b) a first species covalently attached to the fullerene; and (c) a second species endohedrally located in the fullerene.
- 22. The composition of claim 21, wherein the second species is selected from the group consisting of ions, atoms, molecules, and combinations thereof.
- 23. The composition of claim 21, wherein the second species is radioactive.
- 24. The composition of claim 21 further comprising a third species attached to the fullerene, wherein the third species is selected from the group consisting of bio-specific ligands, antibodies, and combinations thereof.
- 25. The composition of claim 21, wherein, the first species is selected from the group consisting of bio-specific ligands and antibodies.
- 26. A composition comprising:
(a) fullerene carbon nanocage; (b) a first species covalently attached to the fullerene carbon nanocage; and (c) a second species endohedrally located in the fullerene carbon nanocage.
- 27. The composition of claim 26, wherein the first species covalently attached to the fullerene carbon nanocage is fluorine.
- 28. The composition of claim 26 further comprising a third species attached to the fullerene, wherein the third species attached to the fullerene carbon nanocage is selected from the group consisting of bio-specific ligands, antibodies, and combinations thereof.
- 29. The composition of claim 26, wherein the second species endohedrally located in the fullerene carbon nanocage is a radioactive species.
- 30. The composition of claim 29, wherein the radioactive species is selected from the group consisting of T+, T2, 3He, cobalt isotopes of small ionic radius, and combinations thereof.
- 31. The method of claim 26, wherein the fullerene carbon nanocage is a fullerene tube.
- 32. The method of claim 31, wherein the fullerene tube is a single-wall carbon nanotube.
- 33. The method of claim 32, wherein the sidewall carbon nanotube is derivatized on the sidewall of the single-wall carbon nanotube.
PRIORITY BENEFIT
[0001] This Application is a continuation-in-part of U.S. patent application Ser. No. 09/787,473, filed Mar. 16, 2001, which is the 35 U.S.C. § 371 national application of International Application No. PCT/US 99/21366, filed Sep. 17, 1999, which designated the United States, claiming priority to U.S. Patent Application Nos. (1) 60/101,092, filed Sep. 18, 1998; (2) 60/106,918 filed Nov. 3, 1998; and (3) 60/138,505, filed Jun. 10, 1999, all of which are hereby incorporated by reference. This Application further claims priority benefits to U.S. Patent Application No. 60/427,431.
GOVERNMENT GRANTS
[0002] This invention was made with United States Government support under (1) United States Grant No. NAGW-4004 awarded by the National Aeronautical and Space Administration—Jet Propulsion Laboratory, (2) United States Grant No. DMR-952225 1 awarded by the National Science Foundation, and (3) United States Grant No. EED-0118007 (Rice CBEN) awarded by the Nanoscale Science and Engineering Initiative of the National Science Foundation. The United States Government may have certain rights in the invention.
Provisional Applications (4)
|
Number |
Date |
Country |
|
60427431 |
Nov 2002 |
US |
|
60138505 |
Jun 1999 |
US |
|
60106918 |
Nov 1998 |
US |
|
60101092 |
Sep 1998 |
US |
Continuation in Parts (1)
|
Number |
Date |
Country |
Parent |
09787473 |
Mar 2001 |
US |
Child |
10716721 |
Nov 2003 |
US |